Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Hexagon Composites ASA: Second quarter and half year results 2021

Hexagon had an active quarter with strong demand and multiple important contract awards. Capacity expansion plans underway based on positive outlook. Highlights in Q2 2021 · Hexagon Agility received orders from major global logistics customer with an estimated total value of USD 23.7 million (approx. NOK 211 million). · Hexagon Agility received an order from Estes Express Lines for compressed natural gas (CNG)/renewable natural gas (RNG) fuel systems with a value of USD 8 million (approx. NOK 71 million) · Empresa Municipal de Transporte (EMT) in Madrid announced a tender

Lehto Group Plc: Half-Year Financial Report January– June 2021

Lehto Group PlcHalf-Year Financial Report 1 January–30 June 202112 August 2021 at 7:30Net sales down by 22%, operating result improved from the comparison period This half-year financial report has been prepared in accordance with the IAS 34 standard. The company complies with half-yearly reporting according to the Finnish Securities Markets Act and discloses regular business reviews for the first three and nine month periods of the year, in which key information regarding the company's financial situation and development will be presented. Summary January–June 2021 []Group

Lehto Group Plc: Changes in Lehto Group Plc's Group Executive Board

Lehto Group PlcInside information12 August 2021 at 7.25 a.m. (EET)Changes will be made to the composition of Lehto Group Plc's Group Executive Board as of August 12, 2021. Juha Höyhtyä, EVP, Housing service area, will leave the Group Executive Board and the company during August 2021. Juuso Hietanen, CEO, will act as director for Housing service area until a successor is found. Jaakko Heikkilä, EVP, Business Premises service area, will leave the Group Executive Board and the company in the end of year 2021. Matti Koskela, an experienced construction professional, will start as

Lundin Gold Reports Second Quarter of 2021 Results

Record operating cash flow supported by lowest quarterly cash operating costs to dateVANCOUVER, BC, August 11, 2021 /CNW/ - Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG) ("Lundin Gold" or the "Company") today reports results for the second quarter and first half of 2021. All amounts are in U.S. dollars unless otherwise indicated. Second Quarter of 2021 Financial Overview · The Company sold a total of 125,412 oz of gold, consisting of 80,486 oz of concentrate and 44,926 oz of doré at an average realized gold price[1] of $1,773 per oz for total gross revenues from gold sales of

Africa Energy Reports Second Quarter 2021 Results

Vancouver, BC, August 11, 2021 /CNW/ – Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”), an oil and gas company with exploration assets offshore South Africa and Namibia, announces financial and operating results for the three and six months ended June 30, 2021. Garrett Soden, the Company’s President and CEO, commented: “We are encouraged by TotalEnergies’ progress on the potential fast-track development of Block 11B/12B offshore South Africa.  The goal of the first phase would be to produce gas and condensate from the Luiperd discovery

Norway Royal Salmon ASA (NRS): NTS ASA – Increase of the Offer Price to NOK 240 per in the mandatory offer to acquire Shares in Norway Royal Salmon ASA – extension of the offer period

This is a copy of the stock exchange announcement from NTS ASA at 21:30 today. NTS ASA («NTS» or the Offeror») has today agreed to acquire in total 378,883 shares in Norway Royal Salmon ASA (“NRS” or the Company”) at NOK 240 per share, equal to approximately 0.87 % of the total number of issued and outstanding shares in NRS. 95 529 of the shares acquired were acquired from related parties of the NTS CEO Harry Bøe, and 39, 384 of the shares were acquired from NTS Chairman of the Board Odd Reidar Øie and related parties. The Offeror thus own directly and indirectly, taking into

Brighter Commences Legal Action Against Unwrap Finance Nordic AB

Brighter AB (publ) (“Brighter” or “the Company”) announced today that the Company has commenced legal action in Attunda District Court against Unwrap Finance Nordic AB ("Unwrap" or “the Counterparty”) to enforce the payment of debts owed to the Company. The legal action relates to certain potential claims mentioned by the Company's auditor in the Annual Report 2020 relating to an investment made in certain debt certificates issued by Unwrap (see press release dated 31 May 2021, Brighter's Auditor Makes Certain Recommendations in the Audit Report for the Fiscal Year 2020 

President and CEO Rasmus Nerman leaves Humana

Humana's President and CEO Rasmus Nerman has informed the Board that he has decided to leave the company, as he has accepted the role of President and CEO of Apoteket AB. The Board is now starting the process of recruiting his successor.After eight years at Humana and six years as President and CEO, Rasmus Nerman leaves the company at his own request. ‒ I have decided to leave Humana for a new challenge and have accepted to become President and CEO of Apoteket AB. I am incredibly proud of Humana's development and I feel very grateful to have been entrusted to lead Humana that has such an

Curando Nordic: Vo2 Cap Holding AB (publ) publishes company description (Cision)

Company description in this case is published today on Curando's website www.curandonordic.se.Full press release: Vo2 Bolagsbeskrivning ‍2021-08-11 16:51 THEINFORMATION IN THIS PRESS RELEASE IS NOT INTENDED TO BE PUBLISHED, PUBLISHED, OR DISTRIBUTED, DIRECTLY, OR IMMEDIATELY, OR , HONG KONG, CANADA, SINGAPORE, OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION SHALL BREACH APPLICABLE LAWS OR RULES. SEE THE "IMPORTANT INFORMATION" SECTION AT THE END OF THIS PRESS RELEASE. The current company Curando Nordic AB (publ) (

Alcadon signs agreement with Deutsche Glasfaser, a leading German provider of FTTH, concerning delivery of products for the FTTH roll-out in Germany with an estimated value of EUR 20 mill per year

Alcadon has through its German Subsidiary Alcadon Gmbh signed a 3 + 1 year contract for delivery of fiber optic materials for the FTTH (Fiber-To-The-Home) build out with Deutsche Glasfaser. It includes deliveries to all contractors for the expansion the FTTH network. The deliveries will commence December 2021. The estimated value of the contract with Deutsche Glasfaser is Euro 20 mill per year.Company group Deutsche GlasfaserThe Deutsche Glasfaser group of companies plans, builds and operates mainly provider-open direct fibre optic connections for private households and companies. It is

Tecnotree Corporation’s share issue to the company itself without consideration

Tecnotree Corporation Stock Exchange Release 11 Aug 2021 at 19:00 EETThe Board of Directors of Tecnotree Corporation has, based on the authorization granted by the Annual General Meeting of Shareholders on 15 May 2019, resolved to issue 5,750,000 new shares to the company itself without consideration in accordance with chapter 9 section 20 of the Limited Liability Companies Act. The shares are of the same series as the company’s other shares and entitle to the same shareholder rights as the company’s existing shares after their registration. The new shares to be issued to the company

Cereno Scientific and Abbott enter collaboration for use of cutting-edge monitor device in upcoming Phase II study with CS1

Cereno Scientific (XSAT: CRNO B) today announced that a collaboration agreement has been entered with global healthcare company Abbott regarding use of its CardioMEMS™ HF System in the upcoming Phase II study with Cereno’s drug candidate CS1. The technology will be used to remotely and continously monitor the pulmonary pressure in the Phase II study evaluating CS1 for the treatment of pulmonary arterial hypertension (PAH). The CardioMEMS device allows Cereno to use a smaller-sized patient population for the Phase II study, which is both more time and cost efficient.“We are passionate about

H1 2021 Interim Financial Report: solid demand across all markets led to strong organic growth and historical high earnings

Today, the Board of Directors of H+H International A/S (hereinafter referred to as “H+H” or “the Group”) has adopted the Interim Financial Report for the first half of 2021 (“H1 2021”). CEO Michael T. Andersen quote “Our markets have quickly recovered from the slowdown seen in early in the year caused by harsh weather conditions and Q2 2021 has showed solid demand across all markets leading to strong organic growth and historical high earnings for H+H—both for the quarter and for the half-year period. The UK market in particular has showed very strong demand and H+H is producing at

Nel ASA: Receives contract for a 1.25 MW containerized PEM electrolyzer for DOE H2@Scale project in the US

(Oslo, 11 August 2021) Nel Hydrogen US, a subsidiary of Nel ASA (Nel, OSE:NEL), has received a contract for a 1.25 megawatt (MW) containerized PEM electrolyzer from a leading utility in the US. Nel Hydrogen US has received a purchase order for a 1.25 MW PEM electrolyzer for installation at a nuclear power plant in the US, a groundbreaking project for carbon-free hydrogen production.  “This project represents an important first step toward developing a regional supply of zero carbon hydrogen, while supporting clean baseload electricity resources on the grid,” says Stephen Szymanski, Vice

Erik Penser Bank has published a Q&A with Attana’s CEO and Head of Diagnostics

Earlier today, Erik Penser Bank published an interview with Attana’s CEO, Teodor Aastrup, and Head of Diagnostics, Samir Fostock, who answer questions from shareholders.The interview, led by equity research analyst Johan Löchen, is held in Swedish and answers questions regarding: · Why did Attana start a new business area within diagnostics? · What is the current status of Attana Diagnostics? · What is the product offering? · What is the sales and marketing strategy? · What does the regulatory plan look like? · How does Attana’s technology differ from ELISA-based

Invitation to presentation of Embracer Group’s Q1 report

Embracer Group hereby invites you to a presentation in connection with the publication of the interim report for the first quarter, the period April-June 2021. The report will be published at 06.00 (CEST) on August 18th and available as of this time at: www.embracer.comThe presentation will be held in English by CEO Lars Wingefors and CFO Johan Ekström, and afterwards a Q&A session will follow, led by analyst Oscar Erixon from Carnegie. Covid-19 Embracer Group safeguards stakeholders' health and strives to help limit the spread of the coronavirus, as well as comply with applicable

ABS and yellow.ai Bring Conversational AI to My Digital Fleet

Technology Capable of Conversing in 100+ Languages Delivers Insights for Shipowners and Charterers in a Significant Industry First(HOUSTON) ABS is launching enterprise-grade, AI-powered chatbots and voicebots on its ABS My Digital Fleet™ risk management platform together with yellow.ai, the world’s leading Conversational AI Platform. This marks an important industry first as no such digital solution has previously been deployed to provide shipping companies with helpful information and support in a conversational manner on a global scale. It is the latest addition to ABS My Digital Fleet’s

#21-268 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-267 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Invitation to Presentation of Immunovia’s Interim Report January – June 2021

LUND (SWEDEN) – Immunovia will publish the company’s interim report for the period January 1 – June 30, 2021 on Thursday, August 19, 2021 at 16:00 CEST. Investors, analysts and media are invited to a telephone conference with web presentation on the same day at 16:30 CEST. CEO Patrik Dahlen will present Immunovia and comment on the interim report. Medical Director Dr. Thomas King, Sr. Marketing Director US Cindy Callahan and CEO Patrik Dahlen will also provide an update about the marketing plans following the launch of the IMMRay[TM]  PanCan-d test. The presentations will be held in

Update on US review of roxadustat

11 August 2021 14:35 BST Update on US regulatory review of roxadustatin anaemia of chronic kidney disease The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the New Drug Application (NDA) for roxadustat for the treatment of anaemia of chronic kidney disease (CKD), in both non-dialysis dependent (NDD) and dialysis-dependent (DD) adult patients. The CRL requested an additional clinical trial on the safety of roxadustat in both the NDD and DD patient populations. AstraZeneca is working with its partner FibroGen, Inc. (FibroGen) and the

Axactor SE - Invitation to presentation of Q2 2021 results

Axactor SE will present the Q2 results 2021 on Tuesday August 17th 2021.The presentation will take place at Hotel Continental, Stortingsgata 24/26, Oslo at 08.30 (CET) The presentation will be held in Norwegian. For attendance at Continental please send an e-mail to Liv Øverby (liv.overby@axactor.com) In addition, there will be a global investor webcast with a live Q&A session at 10.00 (CET). The webcast will be held in English. CEO Johnny Tsolis will present the results. Webcast participation will be possible via the following: Webcast URL: https://streams.eventcdn.net/

Neonode Reports Quarter Ended June 30, 2021 Financial Results

STOCKHOLM, SWEDEN – August 11, 2021 – Neonode Inc. (NASDAQ: NEON), today reported financial results for the three and six months ending June 30, 2021. FINANCIAL SUMMARY FOR THE QUARTER ENDED JUNE 30, 2021: · Revenue of $1.7 million, an increase of 127% compared to the same period in the prior year. · Operating expenses of $3.3 million, an increase of 37.8% compared to the same period in the prior year. · Net loss of $1.7 million, or $0.14 per share, compared to $1.6 million, or $0.18 per share, for the same period in the prior year. · Cash used by operations of $1.4 million

Nel ASA: Invitation to presentation of Q2 2021 results

(Oslo, 11 August 2021) Nel ASA will announce its second quarter 2021 report on Thursday 19 August at 07:00 CET and will host a presentation at 08:00 CET. The presentation will be held at H7-2, Haakon VIIs gate, Oslo at 08:00 CET. The presenter will be Jon André Løkke, CEO. The presentation will be followed by Q&A based on submitted questions during the call. Due to Covid-19 restrictions, physical participation at the presentation in Oslo will be limited. Please contact ir@nelhydrogen.com to register your interest. A confirmation of participation will be needed to access the event.

There are no items matching the current filter
There are no more items matching the current filter
Back to top